Delivery Order SPE2DR25D2009-SPE2DR26FJ4P6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,058.12 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitive award, issued on November 26, 2025, with completion targeted for November 28, 2025, employs firm fixed pricing with no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters....
- The Defense Logistics Agency awarded a $13,166.75 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three. The contract, which is unset-aside and competitively awarded, is scheduled for completion by December 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.90 to AmerisourceBergen Drug Corp for Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging of three units. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of December 12, 2025. The award was issued on December 11, 2025, and the pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,776.11 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg oral disintegrating tablets in unit dose packaging. This non-competitive, firm fixed-price delivery order was executed on December 11, 2025, with an ultimate completion date of December 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,215.11 to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packages of six on August 11, 2025. This firm fixed price delivery order, which is expected to be completed by August 12, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,597.90 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5mg Orally Disintegrating Tablets (ODT) in quantities of three strips. This firm fixed-price delivery order, issued on December 23, 2025, with an ultimate completion date of the same day, was competitively awarded without set-aside designation. The pharmaceutical product will be sourced from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,257.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg oral disintegrating tablets in unit dose packaging (6-count units). The award was made on December 19, 2025, with an ultimate completion date of December 22, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its Corporate Office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,117.48 on December 19, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit-dose packaging. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement procedures. The order is scheduled for completion by December 22, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three. This is a firm fixed-price delivery order with a ceiling value of $33,895.75 and an ultimate completion date of December 17, 2025. The award was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order valued at $3,976.38 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets (ODT) in unit doses of three tablets per package. This contract represents a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The award was issued on September 22, 2025, with an ultimate completion date of September 23, 2025, and the product will be delivered to...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4P6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,018.96 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6-count). This competitively awarded, firm fixed-price delivery order was issued on December 23, 2025, with an ultimate completion date of December 24, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical supply transaction under the federal medical procurement process supporting military and veteran healthcare needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of pharmaceutical products across multiple therapeutic domains. The company's federal contract awards demonstrate consistent capability to deliver both brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/22/25 |